Rosemary Mazanet - Feb 14, 2022 Form 3 Insider Report for Columbia Care Inc. (CCHWF)

Role
Chief Scientific Officer
Signature
/s/ David Sirolly as attorney-in-fact for Rosemary Mazanet
Stock symbol
CCHWF
Transactions as of
Feb 14, 2022
Transactions value $
$0
Form type
3
Date filed
2/14/2022, 05:29 PM
Previous filing
May 27, 2021
Next filing
Apr 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CCHWF Common Shares 1.21M Feb 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CCHWF Proportionate Voting Shares Feb 14, 2022 Common Shares 187 $0.00 Direct F1
holding CCHWF Restricted Stock Units Feb 14, 2022 Common Shares 42K Direct F2, F3
holding CCHWF Restricted Stock Units Feb 14, 2022 Common Shares 38.1K Direct F3, F4
holding CCHWF Restricted Stock Units Feb 14, 2022 Common Shares 43.5K Direct F3, F5
holding CCHWF Resricted Stock Units Feb 14, 2022 Common Share 164K Direct F3, F6
holding CCHWF Restricted Stock Units Feb 14, 2022 Common Shares 72.7K Direct F3, F7
holding CCHWF Performance Stock Units Feb 14, 2022 Common Shares 87.1K Direct F8
holding CCHWF Performance Stock Units Feb 14, 2022 Common Shares 87.1K Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each proportionate voting shares is convertible into 100 common shares of the Issuer. The proportionate voting shares vest on March 31, 2022.
F2 168,094 restricted stock units ("RSUs") were granted on September 28, 2018, with 126,070 RSUs vesting prior to the date of this Form 3. The remaining 42,024 RSUs will vest on March 31, 2022. Settlement of vested RSUs will occur within 60 days of the applicable vesting date.
F3 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F4 76,127 restricted stock units ("RSUs") were granted on September 28, 2018, with 38,063 RSUs vesting prior to the date of this Form 3. The remaining 38,064 RSUs vest as follows: 19,032 on April 29, 2022 and April 29, 2023. Settlement of vested RSUs will occur within 60 days of the applicable vesting date.
F5 174,139 restricted stock units ("RSUs") were granted on April 29, 2019, with 130,604 RSUs vesting prior to the date of this Form 3. The remaining 43,535 RSUs will vest on October 29, 2022. Settlement of vested RSUs will occur within 60 days of the applicable vesting date.
F6 219,102 restricted stock units ("RSUs") were granted on March 31, 2020, with 54,775 RSUs vesting prior to the date of this Form 3. The remaining 164,327 RSUs will vest as follows: 54,776 on March 31, 2022 and March 31, 2024, and 54,775 on March 31, 2023. Settlement of vested RSUs will occur within 60 days of the applicable vesting date.
F7 The restricted stock units ("RSUs") were granted on March 23, 2021, and vest as follows: 18,171 RSUs on March 23, 2022, March 23, 2023, March 23, 2024 and March 23, 2025. Settlement of vested RSUs will occur within 60 days of the applicable vesting date.
F8 The performance stock units ("PSUs") were granted on April 29, 2019. Each PSU represents a contingent right to receive one share of the Issuer's common stock. The PSUs vest upon the Issuer's common stock achieving a specified price per share.

Remarks:

Exhibit 24.1 Power of Attorney